New pill shows promise in early trial for blood cancers
NCT ID NCT05618028
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This early-stage study tests a new drug called ABBV-525 in people with B-cell cancers like lymphoma and leukemia. The goal is to find a safe dose and see if it can shrink tumors. About 78 adults will take the drug by mouth at different doses over several months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center /ID# 266341
Seoul, Seoul Teugbyeolsi, 05505, South Korea
-
Atrium Health Levine Cancer Institute /ID# 246363
Charlotte, North Carolina, 28204, United States
-
Bankstown-Lidcombe Hospital /ID# 260191
Bankstown, New South Wales, 2200, Australia
-
CHRU Lille - Hopital Claude Huriez /ID# 252054
Lille, Nord, 59037, France
-
Charite Universitaetsmedizin Berlin Campus Virchow-Klinikum /ID# 252062
Berlin, 13353, Germany
-
China Medical University Hospital /ID# 266414
Taichung, 40447, Taiwan
-
Fort Wayne Medical Oncology and Hematology, Inc /ID# 250113
Fort Wayne, Indiana, 46804, United States
-
Hadassah Medical Center-Hebrew University /ID# 251441
Jerusalem, Jerusalem, 91120, Israel
-
Hospital Clinic de Barcelona /ID# 246543
Barcelona, 08036, Spain
-
Hospital Universitario 12 de Octubre /ID# 246538
Madrid, 28041, Spain
-
Hospital Universitario Ramon y Cajal /ID# 246540
Madrid, 28034, Spain
-
Hospital Universitario Vall de Hebron /ID# 245475
Barcelona, 08035, Spain
-
IUCT Oncopole /ID# 259409
Toulouse, Occitanie, 31059, France
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center /ID# 259872
Indianapolis, Indiana, 46202-5116, United States
-
Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 246537
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Leeds Teaching Hospitals NHS Trust /ID# 245470
Leeds, West Yorkshire, LS9 7TF, United Kingdom
-
Memorial Sloan Kettering Cancer Center-Koch Center /ID# 245459
New York, New York, 10065-6007, United States
-
Monash Health - Monash Medical Centre /ID# 246366
Clayton, Victoria, 3168, Australia
-
Mount Sinai Medical Center-Miami Beach /ID# 248251
Miami Beach, Florida, 33140-2948, United States
-
National Taiwan University Hospital /ID# 266343
Taipei, 100, Taiwan
-
Northwest Medical Specialties - Tacoma /ID# 260376
Tacoma, Washington, 98405, United States
-
Orange Health Service /ID# 260473
Orange, New South Wales, 2800, Australia
-
Rabin Medical Center. /ID# 257665
Petah Tikva, Central District, 4941492, Israel
-
START Midwest /ID# 252359
Grand Rapids, Michigan, 49546, United States
-
Samsung Medical Center /ID# 266415
Seoul, Seoul Teugbyeolsi, 06351, South Korea
-
Seoul National University Hospital /ID# 266340
Seoul, Seoul Teugbyeolsi, 03080, South Korea
-
Shamir Medical Center /ID# 257711
Beer Ya'akov, Central District, 70300, Israel
-
The Alfred Hospital /ID# 248592
Melbourne, Victoria, 3004, Australia
-
The Chaim Sheba Medical Center /ID# 251442
Ramat Gan, Tel Aviv, 5265601, Israel
-
The Christie Hospital /ID# 250325
Manchester, M20 4BX, United Kingdom
-
The Royal Marsden NHS Foundation Trust /ID# 250324
London, SW3 6JJ, United Kingdom
-
Tulane Cancer Center Clinic /ID# 249586
New Orleans, Louisiana, 70112, United States
-
UZ Gent /ID# 246462
Ghent, Oost-Vlaanderen, 9000, Belgium
-
Universitair Ziekenhuis Leuven /ID# 246461
Leuven, Vlaams-Brabant, 3000, Belgium
-
University Of Cincinnati Medical Center /ID# 262288
Cincinnati, Ohio, 45219, United States
-
University of California Los Angeles Medical Center /ID# 246357
Los Angeles, California, 90095, United States
-
University of Texas MD Anderson Cancer Center /ID# 245463
Houston, Texas, 77030, United States
-
University of Utah Health Hospital /ID# 259924
Salt Lake City, Utah, 84132, United States
-
Yale University School of Medicine /ID# 259081
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.